Music Therapy for Delirium
(DyNamic Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new music therapy to help prevent delirium, a type of confusion, in hospital patients. It targets individuals with brain diseases such as Alzheimer's and Parkinson's. Participants will receive up to five personalized sessions, which may include live music, playing instruments, or listening to recordings. Ideal candidates are those staying at Boston Medical Center with cognitive impairments, who enjoy music, and are not heavily sedated. The trial aims to assess the feasibility and benefits of this therapy for future patients. As an unphased trial, participants contribute to innovative research that may enhance future care for individuals with cognitive impairments.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this music therapy is safe for patients with brain diseases?
Past studies have shown that music therapy helps reduce the severity of delirium. Research indicates that music therapy is safe and well-tolerated by patients. For example, one study found that using music in the intensive care unit (ICU) significantly reduced delirium without causing harm. Another study suggested that early treatments like music therapy, which do not involve drugs, better ensure patient safety.
Overall, music therapy does not use drugs or involve invasive procedures, making it a low-risk option. Participants often find it calming and helpful. This makes it a safe choice for those interested in joining studies on music therapy for delirium.12345Why are researchers excited about this trial?
Researchers are excited about music therapy for delirium because it offers a non-drug approach that taps into the emotional and cognitive aspects of the brain. Unlike traditional treatments that primarily rely on medications like antipsychotics, music therapy uses personalized sessions involving re-creation, composition, improvisation, and therapeutic listening to engage patients in a meaningful way. This approach not only aims to reduce symptoms of delirium but also enhances patients' overall well-being by fostering a sense of connection and calmness without the side effects often associated with medications.
What evidence suggests that music therapy might be an effective treatment for delirium?
Research has shown that music therapy might help reduce symptoms of confusion, known as delirium. Some studies found that listening to slow music can significantly lower the risk of delirium in ICU patients. Other studies have shown fewer delirium episodes and better assessments of delirium after music therapy. This trial will focus on one-on-one music therapy sessions, customized to address patient needs. While not all studies show strong results, the overall trend is promising for using music therapy to help prevent confusion in patients with brain conditions, especially in hospitals.23678
Who Is on the Research Team?
Kara M Smith, MD MSCI FAAN
Principal Investigator
Boston Medical Center, Neurology
Are You a Good Fit for This Trial?
This trial is for patients with brain diseases like Alzheimer's and Parkinson's who are hospitalized and at risk of delirium. The study aims to enroll around 30 participants who will undergo personalized music therapy sessions designed to prevent confusion during hospital stays.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo up to five music therapy sessions, each approximately 30 minutes, conducted by a board-certified music therapist.
Follow-up
Participants are monitored for safety and effectiveness after treatment using delirium scores and other measures.
What Are the Treatments Tested in This Trial?
Interventions
- Music Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston Medical Center
Lead Sponsor